SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-24-002875
Filing Date
2024-02-13
Accepted
2024-02-12 21:56:48
Documents
8
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 5469
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 336550
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 184303
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 6790
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6784
6 GRAPHIC exhibit99-2x002.jpg GRAPHIC 24458
7 GRAPHIC exhibit99-2x003.jpg GRAPHIC 56218
8 GRAPHIC exhibit99-2x004.jpg GRAPHIC 36268
  Complete submission text file 0001062993-24-002875.txt   702430
Mailing Address 19 VESTRY STREET NEW YORK NY 10013
Business Address 19 VESTRY STREET NEW YORK NY 10013 6474072515
BRIGHT MINDS BIOSCIENCES INC. (Filer) CIK: 0001827401 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-40997 | Film No.: 24622394
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)